| Laura Stogner, DNP STUDENT | |
|
4301 Jones Bridge Road, Apo, AA 20814 | |
| (301) 295-9004 | |
| Not Available |
| Full Name | Laura Stogner |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 4301 Jones Bridge Road, Apo, Armed Forces Americas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386988780 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Stogner, DNP STUDENT 4301 Jones Bridge Rd, Bethesda, MD 20814-4712 Ph: (301) 649-1840 | Laura Stogner, DNP STUDENT 4301 Jones Bridge Road, Apo, AA 20814 Ph: (301) 295-9004 |
News Archive
The American Society for Reproductive Medicine (ASRM) publishes the first validation study on the ASRM Embryo Transfer Simulator, showing significant improvements in Embryo Transfer competence.
Attorneys for GOP-controlled states seeking to kill the Affordable Care Act told the Supreme Court last week that at least some of the 12 million people who newly enrolled in Medicaid signed up only because of the law's requirement that people have insurance coverage — although a tax penalty no longer exists.
University of Tennessee, Knoxville, researchers have found that blue-green algae may be responsible for producing an estrogen-like compound in the environment which could disrupt the normal activity of reproductive hormones and adversely affect fish, plants and human health.
"Business as usual" won't be this flu season, with the effects of the H1N1 (Swine Flu) pandemic expected to include quarantines, travel restrictions and school and office closings. Businesses that rely on travel need to make preparations now to mitigate the impact.
For about 20 years, the Food and Drug Administration (FDA) has charged pharmaceutical companies "user fees" for reviewing drug-approval applications. The revenue allows the FDA to hire more evaluators, which allows useful drugs to reach patients faster. Now the Prescription Drug User Fee Act needs reauthorization, as it does every five years. Legislators should not dillydally.
› Verified 1 days ago